Back to results
US 11,433,096 B2Granted
Ophthalmic formulation and methods of use
OwnerAbdelhamid Muhammad AlQallawi, Sherif Abdelhamid AlQallawiinventors
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for an eye drop and medication. Accordingly, the eye drop and medication have the potential for the provision of and pioneering non-surgical treatment of eye conditions.
Claims14
A method of treating cataract condition, comprising:
- delivering therapeutically effective concentrations of a zinc compound and at least one antihistamine for the treatment of an eye condition, wherein the antihistamine is Chlorpheniramine Maleate.
A method of treating posterior capsular opacification, comprising:
- delivering therapeutically effective concentrations of a zinc compound and at least one antihistamine for the treatment of an eye condition, wherein the antihistamine is Chlorpheniramine Maleate, and delivering therapeutically effective concentrations address surgical complications/side effects.
A method of treating blindness, comprising:
- delivering therapeutically effective concentrations of a zinc compound and at least one antihistamine for the treatment of an eye condition, wherein the antihistamine is Chlorpheniramine Maleate, and delivering therapeutically effective concentrations to restore vision.
A method of treating glaucoma, comprising:
- delivering therapeutically effective concentrations of a zinc compound and at least one antihistamine for the treatment of an eye condition, wherein the antihistamine is Chlorpheniramine Maleate, and delivering therapeutically effective concentrations to reduce eye pressure to treat acute and chronic glaucoma.
Dependencies are inferred from the claim text.